首页> 外文OA文献 >Gender effect on phenotype and genotype in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis: results from the MYSEC project

【2h】

Gender effect on phenotype and genotype in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis: results from the MYSEC project

机译：性能对多胆症后患者表型和基因型的性别效应和髓细胞后血栓性血小伤症的表型和基因型：MYSEC项目的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Daniela Barraco; Barbara Mora; Paola Guglielmelli; Elisa Rumi; Margherita Maffioli; Alessandro Rambaldi; Marianna Caramella; Rami Komrokji; Jason Gotlib; Jean Jacques Kiladjian; Francisco Cervantes; Timothy Devos; Francesca Palandri; Valerio De Stefano; Marco Ruggeri; Richard T. Silver; Giulia Benevolo; Francesco Albano; Michele Merli; Daniela Pietra; Tiziano Barbui; Giada Rotunno; Mario Cazzola; Toni Giorgino; Alessandro Maria Vannucchi; Francesco Passamonti;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Differences in presenting features, outcome and prognostic models in patients with primary myelofibrosis and post-polycythemia vera and/or post-essential thrombocythemia myelofibrosis treated with ruxolitinib. New perspective of the MYSEC-PM in a large multicenter study [J] . Palandri Francesca, Palumbo Giuseppe A., Iurlo Alessandra, Seminars in Hematology . 2018,第4期

机译：用Ruxolitinib治疗原发性髓纤维化患者的特征，结果和预后模型及其后血压血肿和/或基本血小盲血肿性脓毒症。大型多中心研究中Mysec-PM的新视角
2. JAK2V617F mutational status and allele burden have little influence on clinical phenotype and prognosis in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis | Haematologica [J] . Paola Guglielmelli, Giovanni Barosi, Lisa Pieri, Haematologica . 2009,第1期

机译：JAK2V617F突变状态和等位基因负荷对真性红细胞增多症和实质性血小板增多性骨髓纤维化患者的临床表型和预后影响不大血液学
3. Population pharmacokinetic analysis of orally-administered ruxolitinib (incb018424 phosphate) in patients with primary myelofibrosis (pmf), post-polycythemia vera myelofibrosis (PPV-MF) or post-essential thrombocythemia myelofibrosis (PET MF) [J] . ChenX., WilliamsW.V., SandorV., The Journal of Clinical Pharmacology: Official Journal of the American College of Clinical Pharmacology . 2013,第7期

机译：原发性骨髓纤维化（pmf），真性红细胞增多症后真性骨髓纤维化（PPV-MF）或实质性血小板增多性骨髓炎（PET MF）患者口服ruxolitinib（incb018424磷酸盐）的群体药代动力学分析
4. Large Scale Phenotyping and Data Analysis of Pepper Genotypes in the EU-SPICY Project [C] . J.A. Dieleman, J.J. Magan, A.M. Wubs, International Horticulture Congress on Science and Horticulture for People . 2012

机译：欧盟辛辣工程中辣椒基因型的大规模表型和数据分析
5. Environmental Etiology of Polycythemia Vera, Essential Thrombocythemia and Primary Myelofibrosis: A Case-Control Study in Northeast Pennsylvania. [D] . Gross-Davis, Carol Ann. 2014

机译：真性红细胞增多症，原发性血小板增多症和原发性骨髓纤维化的环境病因：宾夕法尼亚州东北部的病例对照研究。
6. Gender effect on phenotype and genotype in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis: results from the MYSEC project [O] . Daniela Barraco, Barbara Mora, Paola Guglielmelli, 2018

机译：性别对真性红细胞增多症和实质性血小板增多性骨髓纤维化患者表型和基因型的影响：MYSEC项目的结果
7. Differences in presenting features, outcome and prognostic models in patients with primary myelofibrosis and post-polycythemia vera and/or post-essential thrombocythemia myelofibrosis treated with ruxolitinib. New perspective of the MYSEC-PM in a large multicenter study⁎ [O] . Francesca Palandri, Giuseppe A. Palumbo, Alessandra Iurlo, 2018

机译：用Ruxolitinib治疗原发性髓OERIBIB病患者和/或多胆症后血小心患者的特征，结果和预后模型的差异。大型多中心研究中的Mysec-PM的新视角

Gender effect on phenotype and genotype in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis: results from the MYSEC project

著录项

引文网络

相似文献

相关主题

期刊订阅